Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell-originated protein kinase (TOPK)
- Target
- TOPK
- Molecular classification
- Enzyme, Serine/threonine kinase, MAPKK family
01
Overview
T-cell-originated protein kinase (TOPK), also known as PBK, is a serine/threonine kinase belonging to the MAPKK family. It plays a critical role in cell division, particularly in regulating cytokinesis during mitosis. TOPK is highly expressed in various tumor tissues and is linked to enhanced proliferation, increased migration/invasion, tumor metastasis, and drug resistance. It serves as a prognostic biomarker and a therapeutic target for multiple cancers. Inhibitors like OTS514 have shown promise in suppressing cancer cell growth and enhancing sensitivity to chemotherapy.
- Other names
- PBKPDZ-binding kinaseT-LAK cell-originated protein kinaseLymphokine-activated killer T-cell-originated protein kinase
02
Mechanism of action
Inhibition of TOPK suppresses proliferation/migration of cancer cells, promotes apoptosis, and enhances sensitivity to chemotherapeutics.
03
Biological functions
Cell cycleMitotic regulationCell proliferationCytokinesisLymphoid cell activationSpermatogenesis
04
Disease associations
Cancer
05
Safety considerations
Potential for off-target effects due to kinase similarityToxicity associated with cell cycle inhibition
06
Interacting drugs
OTS514
2 more in the full profile.
07
Biomarkers
TOPK expression level in tumor tissue
Beyond the preview
Go deeper on T-cell-originated protein kinase (TOPK).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on T-cell-originated protein kinase (TOPK).